D.M. Barends

3.9k total citations
68 papers, 3.1k citations indexed

About

D.M. Barends is a scholar working on Pharmaceutical Science, Analytical Chemistry and Spectroscopy. According to data from OpenAlex, D.M. Barends has authored 68 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pharmaceutical Science, 32 papers in Analytical Chemistry and 21 papers in Spectroscopy. Recurrent topics in D.M. Barends's work include Drug Solubulity and Delivery Systems (32 papers), Analytical Methods in Pharmaceuticals (31 papers) and Analytical Chemistry and Chromatography (21 papers). D.M. Barends is often cited by papers focused on Drug Solubulity and Delivery Systems (32 papers), Analytical Methods in Pharmaceuticals (31 papers) and Analytical Chemistry and Chromatography (21 papers). D.M. Barends collaborates with scholars based in Netherlands, Germany and United States. D.M. Barends's co-authors include Vinod P. Shah, Jennifer Dressman, Hans E. Junginger, K.K. Midha, S. Stavchansky, Gordon L. Amidon, Sabine Kopp, A. Hulshoff, Henderik W. Frijlink and James E. Polli and has published in prestigious journals such as Journal of Chromatography A, Analytica Chimica Acta and International Journal of Pharmaceutics.

In The Last Decade

D.M. Barends

68 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.M. Barends Netherlands	35	1.4k	755	562	432	412	68	3.1k
Ajaz Hussain United States	22	1.2k 0.8×	558 0.7×	371 0.7×	400 0.9×	394 1.0×	63	2.7k
Sandra Klein Germany	27	1.9k 1.3×	407 0.5×	292 0.5×	580 1.3×	368 0.9×	99	3.0k
Filippos Kesisoglou United States	34	2.3k 1.6×	488 0.6×	488 0.9×	877 2.0×	695 1.7×	90	3.5k
Gregory E. Amidon United States	31	2.5k 1.8×	585 0.8×	493 0.9×	1.0k 2.4×	695 1.7×	58	4.1k
Jerome P. Skelly United States	27	964 0.7×	799 1.1×	648 1.2×	230 0.5×	1.1k 2.7×	70	4.7k
Sabine Kopp Switzerland	22	1.0k 0.7×	373 0.5×	311 0.6×	420 1.0×	304 0.7×	34	1.9k
Maria Vertzoni Greece	35	3.0k 2.1×	711 0.9×	699 1.2×	1.0k 2.4×	552 1.3×	114	4.1k
Marival Bermejo Spain	34	1.8k 1.3×	447 0.6×	599 1.1×	644 1.5×	1.0k 2.5×	143	4.6k
Jong Soo Woo South Korea	31	1.7k 1.2×	334 0.4×	265 0.5×	449 1.0×	597 1.4×	118	3.4k
Henning Gjelstrup Kristensen Denmark	34	1.6k 1.1×	269 0.4×	292 0.5×	539 1.2×	567 1.4×	68	3.2k

Countries citing papers authored by D.M. Barends

Since Specialization

Citations

This map shows the geographic impact of D.M. Barends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.M. Barends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.M. Barends more than expected).

Fields of papers citing papers by D.M. Barends

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.M. Barends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.M. Barends. The network helps show where D.M. Barends may publish in the future.

Co-authorship network of co-authors of D.M. Barends

This figure shows the co-authorship network connecting the top 25 collaborators of D.M. Barends. A scholar is included among the top collaborators of D.M. Barends based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.M. Barends. D.M. Barends is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dressman, Jennifer, Anita Nair, Bertil Abrahamsson, et al.. (2012). Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Acetylsalicylic Acid. Journal of Pharmaceutical Sciences. 101(8). 2653–2667. 53 indexed citations

Cristofoletti, Rodrigo, Sı́lvia Storpirtis, Hans E. Junginger, et al.. (2011). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levofloxacin. Journal of Pharmaceutical Sciences. 100(5). 1628–1636. 48 indexed citations

Jantratid, Ekarat, Jennifer Dressman, Hans E. Junginger, et al.. (2011). COMMENTARY: Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Lamivudine. Journal of Pharmaceutical Sciences. 100(6). 2054–2063. 33 indexed citations

Jantratid, Ekarat, Jennifer Dressman, Hans E. Junginger, et al.. (2010). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Mefloquine Hydrochloride. Journal of Pharmaceutical Sciences. 100(1). 11–21. 22 indexed citations

Becker, Corina, Jennifer Dressman, Hans E. Junginger, et al.. (2009). Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin. Journal of Pharmaceutical Sciences. 98(7). 2252–2267. 64 indexed citations

Granero, Gladys E., Marcela R. Longhi, Hans E. Junginger, et al.. (2009). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Furosemide. Journal of Pharmaceutical Sciences. 99(6). 2544–2556. 126 indexed citations

Benet, Leslie Z., Gordon L. Amidon, D.M. Barends, et al.. (2008). The Use of BDDCS in Classifying the Permeability of Marketed Drugs. Pharmaceutical Research. 25(3). 483–488. 100 indexed citations

Langguth, Peter, Hans E. Junginger, Sabine Kopp, et al.. (2008). Biowaiver monographs for immediate release solid oral dosage forms: Quinidine sulfate. Journal of Pharmaceutical Sciences. 98(7). 2238–2251. 12 indexed citations

Becker, Corina, Jennifer Dressman, Gordon L. Amidon, et al.. (2008). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Pyrazinamide**A project of the International Pharmaceutical Federation FIP, Groupe BCS, www.fip.org/bcs.**This article reflects the scientific opinion of the authors and not the policies of regulating agencies.. Journal of Pharmaceutical Sciences. 97(9). 3709–3720. 44 indexed citations

10.

Junginger, Hans E., Sabine Kopp, K.K. Midha, et al.. (2008). Biowaiver Monographs for Immediate Release Solid Oral Dosage forms: Metoclopramide Hydrochloride. Journal of Pharmaceutical Sciences. 97(9). 3700–3708. 36 indexed citations

11.

Vogt, Markus, Hartmut Derendorf, Johannes Krämer, et al.. (2007). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Prednisone. Journal of Pharmaceutical Sciences. 96(6). 1480–1489. 38 indexed citations

12.

Vogt, Markus, Hartmut Derendorf, Johannes Krämer, et al.. (2006). Biowaiver Monographs for Immediate Release Solid OralDosage Forms: Prednisolone. Journal of Pharmaceutical Sciences. 96(1). 27–37. 58 indexed citations

13.

Manzo, Rubén H., Marı́a Eugenia Olivera, Gordon L. Amidon, et al.. (2006). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Amitriptyline Hydrochloride**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.. Journal of Pharmaceutical Sciences. 95(5). 966–973. 44 indexed citations

14.

Verbeeck, Roger K., Hans E. Junginger, K.K. Midha, Vinod P. Shah, & D.M. Barends. (2005). Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride**This study reflects the scientific opinion of the authors and not the policies of regulating agencies.. Journal of Pharmaceutical Sciences. 94(7). 1389–1395. 45 indexed citations

15.

Potthast, Henrike, Jennifer Dressman, Hans E. Junginger, et al.. (2005). Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ibuprofen**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.. Journal of Pharmaceutical Sciences. 94(10). 2121–2131. 194 indexed citations

16.

Vredenbregt, M.J., Leonore Blok‐Tip, R Hoogerbrugge, D.M. Barends, & D. de Kaste. (2005). Screening suspected counterfeit Viagra® and imitations of Viagra® with near-infrared spectroscopy. Journal of Pharmaceutical and Biomedical Analysis. 40(4). 840–849. 100 indexed citations

17.

Kalantzi, Lida, Christos Reppas, Jennifer Dressman, et al.. (2005). Biowaiver monographs for immediate release solid oral dosage forms: Acetaminophen (paracetamol). Journal of Pharmaceutical Sciences. 95(1). 4–14. 138 indexed citations

18.

Vredenbregt, M.J., et al.. (2003). Choice and validation of a near infrared spectroscopic application for the identity control of starting materials.. European Journal of Pharmaceutics and Biopharmaceutics. 56(3). 489–499. 15 indexed citations

19.

Weda, M, Pieter Zanen, Anne H. de Boer, et al.. (2002). Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy. International Journal of Pharmaceutics. 249(1-2). 247–255. 26 indexed citations

20.

Olling, M, et al.. (1999). Bioavailability of carbamazepine from four different products and the occurrence of side effects. Biopharmaceutics & Drug Disposition. 20(1). 19–28. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact